{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:32:36Z","timestamp":1768437156661,"version":"3.49.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,15]]},"DOI":"10.1093\/hmg\/dds471","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T02:37:46Z","timestamp":1351823866000},"page":"633-645","source":"Crossref","is-referenced-by-count":75,"title":["Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds"],"prefix":"10.1093","volume":"22","author":[{"given":"Gustavo","family":"Tiscornia","sequence":"first","affiliation":[]},{"given":"Erika","family":"Lorenzo Vivas","sequence":"additional","affiliation":[]},{"given":"Leslie","family":"Matalonga","sequence":"additional","affiliation":[]},{"given":"Ina","family":"Berniakovich","sequence":"additional","affiliation":[]},{"given":"Montserrat","family":"Barrag\u00e1n Monasterio","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Eguiz\u00e1bal","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Gort","sequence":"additional","affiliation":[]},{"given":"Federico","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Ortiz Mellet","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Garc\u00eda Fern\u00e1ndez","sequence":"additional","affiliation":[]},{"given":"Antonia","family":"Ribes","sequence":"additional","affiliation":[]},{"given":"Anna","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Juan Carlos","family":"Izpisua Belmonte","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2012,10,31]]},"reference":[{"key":"key\n\t\t\t\t20170522170308_DDS471C1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0021-9258(18)97611-8","article-title":"The metabolism of glucocerebrosides. I. Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue","volume":"240","author":"Brady","year":"1965","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522170308_DDS471C3","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522170308_DDS471C4","first-page":"3635","author":"Beutler","year":"2001","journal-title":"The Metabolic and Molecular Bases of Inherited Disease"},{"key":"key\n\t\t\t\t20170522170308_DDS471C5","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522170308_DDS471C6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522170308_DDS471C7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522170308_DDS471C8","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/archneur.1993.00540110088009","article-title":"The role of neurogenetics in Gaucher disease","volume":"50","author":"Brady","year":"1993","journal-title":"Arch Neurol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C9","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0010021","article-title":"Enzyme replacement in Gaucher disease","volume":"1","author":"Beutler","year":"2004","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170522170308_DDS471C10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","article-title":"Substrate reduction therapy of glycosphingolipid storage disorders","volume":"29","author":"Aerts","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170522170308_DDS471C11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/13543776.2011.569162","article-title":"Pharmacological chaperone therapy for Gaucher disease: a patent review","volume":"21","author":"Benito","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"key\n\t\t\t\t20170522170308_DDS471C12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"key\n\t\t\t\t20170522170308_DDS471C13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","volume":"9","author":"Valenzano","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C14","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood\u2013brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522170308_DDS471C15","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"key\n\t\t\t\t20170522170308_DDS471C16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170522170308_DDS471C17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0950-3536(97)80036-4","article-title":"Gaucher's disease: the best laid schemes of mice and men","volume":"10","author":"Sidransky","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C18","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522170308_DDS471C20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522170308_DDS471C21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522170308_DDS471C22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature05944","article-title":"In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state","volume":"448","author":"Wernig","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522170308_DDS471C23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature08792","article-title":"Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients","volume":"464","author":"Agarwal","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522170308_DDS471C24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature09005","article-title":"Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome","volume":"465","author":"Carvajal-Vergara","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522170308_DDS471C25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522170308_DDS471C26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522170308_DDS471C27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature08320","article-title":"Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs","volume":"461","author":"Lee","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522170308_DDS471C28","doi-asserted-by":"crossref","first-page":"15768","DOI":"10.1073\/pnas.0906894106","article-title":"Generation of pluripotent stem cells from patients with type 1 diabetes","volume":"106","author":"Maehr","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522170308_DDS471C29","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-specific induced pluripotent stem-cell models for long-QT syndrome","volume":"363","author":"Moretti","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522170308_DDS471C30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522170308_DDS471C31","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/nm.2504","article-title":"Diseases in a dish: modeling human genetic disorders using induced pluripotent cells","volume":"17","author":"Tiscornia","year":"2011","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522170308_DDS471C32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2010-05-287607","article-title":"Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)","volume":"117","author":"Tolar","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170522170308_DDS471C33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.stem.2010.04.005","article-title":"Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells","volume":"6","author":"Urbach","year":"2010","journal-title":"Cell Stem Cell"},{"key":"key\n\t\t\t\t20170522170308_DDS471C34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/mt.2010.269","article-title":"Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells","volume":"19","author":"Kambal","year":"2011","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170522170308_DDS471C35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/gt.2011.22","article-title":"Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy","volume":"18","author":"Senju","year":"2011","journal-title":"Gene Ther."},{"key":"key\n\t\t\t\t20170522170308_DDS471C36","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.exphem.2008.04.009","article-title":"Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3","volume":"36","author":"Karlsson","year":"2008","journal-title":"Exp. Hematol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nprot.2010.184","article-title":"Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells","volume":"6","author":"Choi","year":"2011","journal-title":"Nat. Protoc."},{"key":"key\n\t\t\t\t20170522170308_DDS471C38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.stem.2009.09.008","article-title":"Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2","volume":"5","author":"Giorgetti","year":"2009","journal-title":"Cell Stem Cell"},{"key":"key\n\t\t\t\t20170522170308_DDS471C39","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/nprot.2008.188","article-title":"Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale","volume":"3","author":"Cho","year":"2008","journal-title":"Nat. Protoc."},{"key":"key\n\t\t\t\t20170522170308_DDS471C40","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1073\/pnas.0712359105","article-title":"Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells","volume":"105","author":"Cho","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522170308_DDS471C41","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1371\/journal.pone.0004792","article-title":"A plant-derived recombinant human glucocerebrosidase enzyme\u2014a preclinical and phase I investigation","volume":"4","author":"Aviezer","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170522170308_DDS471C42","doi-asserted-by":"crossref","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","article-title":"Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses","volume":"15","author":"Butters","year":"2005","journal-title":"Glycobiology"},{"key":"key\n\t\t\t\t20170522170308_DDS471C43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nrd3311","article-title":"Velaglucerase alfa","volume":"9","author":"Aerts","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20170522170308_DDS471C44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522170308_DDS471C45","first-page":"407","article-title":"Review of the safety and efficacy of imiglucerase treatment of Gaucher disease","volume":"3","author":"Elstein","year":"2009","journal-title":"Biologics"},{"key":"key\n\t\t\t\t20170522170308_DDS471C46","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522170308_DDS471C47","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522170308_DDS471C48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(98)90023-6","article-title":"Enzyme therapy for Gaucher disease: the first 5 years","volume":"12","author":"Grabowski","year":"1998","journal-title":"Blood Rev."},{"key":"key\n\t\t\t\t20170522170308_DDS471C49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1010335505357","article-title":"Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy","volume":"24","author":"Platt","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170522170308_DDS471C50","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"key\n\t\t\t\t20170522170308_DDS471C52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004310000630","article-title":"Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb","volume":"160","author":"Aoki","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"key\n\t\t\t\t20170522170308_DDS471C53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<16::AID-AJMG3>3.0.CO;2-O","article-title":"Gaucher disease: enzyme therapy in the acute neuronopathic variant","volume":"71","author":"Prows","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"key\n\t\t\t\t20170522170308_DDS471C54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0165-6147(00)01575-3","article-title":"Pharmacological chaperones: a new twist on receptor folding","volume":"21","author":"Morello","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"key\n\t\t\t\t20170522170308_DDS471C55","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1111\/j.1742-4658.2007.06042.x","article-title":"Pharmacologic chaperoning as a strategy to treat Gaucher disease","volume":"274","author":"Yu","year":"2007","journal-title":"FEBS J."},{"key":"key\n\t\t\t\t20170522170308_DDS471C56","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem. Biol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C57","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522170308_DDS471C58","volume-title":"Iminosugars: From Synthesis to Therapeutic Applictions","author":"Suzuki","year":"2007"},{"key":"key\n\t\t\t\t20170522170308_DDS471C59","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/cbic.200900442","article-title":"Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin","volume":"10","author":"Luan","year":"2009","journal-title":"Chembiochem"},{"key":"key\n\t\t\t\t20170522170308_DDS471C60","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1073\/pnas.0901471106","article-title":"Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector","volume":"106","author":"Gonzalez","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522170308_DDS471C61","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/hmg\/ddr424","article-title":"Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification","volume":"20","author":"Huang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522170308_DDS471C62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature08129","article-title":"Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells","volume":"460","author":"Raya","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522170308_DDS471C63","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/ng.471","article-title":"Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts","volume":"41","author":"Doi","year":"2009","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522170308_DDS471C64","doi-asserted-by":"crossref","first-page":"e8975","DOI":"10.1371\/journal.pone.0008975","article-title":"Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells","volume":"5","author":"Ghosh","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170522170308_DDS471C65","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522170308_DDS471C66","doi-asserted-by":"crossref","first-page":"e7076","DOI":"10.1371\/journal.pone.0007076","article-title":"Transcriptional signature and memory retention of human-induced pluripotent stem cells","volume":"4","author":"Marchetto","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170522170308_DDS471C67","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nbt.1667","article-title":"Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells","volume":"28","author":"Polo","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20170522170308_DDS471C68","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522170308_DDS471C69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522170308_DDS471C70","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","article-title":"Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency","volume":"107","author":"Hu","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522170308_DDS471C71","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/stem.657","article-title":"Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines","volume":"29","author":"Woods","year":"2011","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t20170522170308_DDS471C72","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ. Res."},{"key":"key\n\t\t\t\t20170522170308_DDS471C73","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ymgme.2006.01.010","article-title":"Lysosomal storage diseases: natural history and ethical and economic aspects","volume":"88","author":"Beutler","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522170308_DDS471C74","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/cbic.201000323","article-title":"A Fluorescent sp2-iminosugar with pharmacological chaperone activity for Gaucher disease: synthesis and intracellular distribution studies","volume":"11","author":"Luan","year":"2010","journal-title":"Chembiochem."},{"key":"key\n\t\t\t\t20170522170308_DDS471C75","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/B:BOLI.0000042959.44318.7c","article-title":"Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease","volume":"27","author":"Schueler","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170522170308_DDS471C76","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1039\/c1ob05234a","article-title":"Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards beta-glucocerebrosidase","volume":"9","author":"Aguilar-Moncayo","year":"2011","journal-title":"Org Biomol. Chem."},{"key":"key\n\t\t\t\t20170522170308_DDS471C77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/(SICI)1096-8628(19970627)70:4<437::AID-AJMG19>3.0.CO;2-I","article-title":"Two new mild homozygous mutations in Gaucher disease patients: clinical signs and biochemical analyses","volume":"70","author":"Cormand","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"key\n\t\t\t\t20170522170308_DDS471C78","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/abio.1997.2090","article-title":"A flow cytometric assay for lysosomal glucocerebrosidase","volume":"247","author":"van Es","year":"1997","journal-title":"Anal. Biochem."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/22\/4\/633\/13930242\/dds471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T19:55:10Z","timestamp":1643572510000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/dds471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,31]]},"references-count":78,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,10,31]]},"published-print":{"date-parts":[[2013,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/dds471","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,31]]}}}